BR100 Increased By (1.02%)
BR30 Increased By (1.71%)
KSE100 Increased By (0.58%)
KSE30 Increased By (0.65%)
BECO 6.03 Increased By ▲ 0.26 (4.51%)
BML 52.61 Decreased By ▼ -0.39 (-0.74%)
BOP 34.23 Increased By ▲ 0.24 (0.71%)
CNERGY 8.16 Increased By ▲ 0.05 (0.62%)
DCL 12.23 Increased By ▲ 0.03 (0.25%)
FCCL 53.80 Increased By ▲ 0.97 (1.84%)
FCSC 5.24 Increased By ▲ 0.17 (3.35%)
FFL 18.03 Increased By ▲ 0.08 (0.45%)
FNEL 1.30 Increased By ▲ 0.01 (0.78%)
HUMNL 11.00 Increased By ▲ 0.12 (1.1%)
KEL 8.07 Increased By ▲ 0.05 (0.62%)
KOSM 5.39 Decreased By ▼ -0.13 (-2.36%)
MLCF 87.90 Increased By ▲ 1.39 (1.61%)
NBP 186.60 Increased By ▲ 1.44 (0.78%)
PACE 10.75 Increased By ▲ 0.17 (1.61%)
PAEL 39.95 Increased By ▲ 0.53 (1.34%)
PIAHCLA 26.19 Decreased By ▼ -0.03 (-0.11%)
PIBTL 17.32 Increased By ▲ 0.65 (3.9%)
PPL 233.49 Increased By ▲ 5.31 (2.33%)
PRL 34.98 Increased By ▲ 0.30 (0.87%)
PTC 67.71 Increased By ▲ 2.38 (3.64%)
SEARL 90.90 Increased By ▲ 0.77 (0.85%)
SSGC 27.20 Increased By ▲ 0.60 (2.26%)
TELE 8.57 Increased By ▲ 0.29 (3.5%)
THCCL 60.85 Increased By ▲ 2.35 (4.02%)
TPLP 8.78 Increased By ▲ 0.56 (6.81%)
TREET 24.65 Increased By ▲ 0.12 (0.49%)
TRG 71.50 Increased By ▲ 1.79 (2.57%)
WAVES 10.01 Increased By ▲ 0.07 (0.7%)
WTL 1.27 Decreased By ▼ -0.01 (-0.78%)
World

Study finds 1 in 10 people in Spain has been infected with virus

  • The sero-prevalence study, presented late on Tuesday, is now in its fourth round. Its work involved carrying out rapid antibody tests on 51,409 people across the country of some 47 million people between November 16 and 29.
Published December 16, 2020 Updated December 16, 2020 05:02pm
By

MADRID: Around 4.7 million people in Spain, which amounts to one in 10 people, have contracted the coronavirus since the start of the pandemic, according to a new government-led antibody study.

The figure is significantly higher than the health ministry official tally, which now sits at 1.76 million. It is higher too than the estimate of over three million Covid-19 cases announced by Prime Minister Pedro Sanchez in October.

The sero-prevalence study, presented late on Tuesday, is now in its fourth round. Its work involved carrying out rapid antibody tests on 51,409 people across the country of some 47 million people between November 16 and 29.

The results of the previous round of the study, published in July, found a prevalence rate of just over 5.0 percent.

The infection rate in Madrid was the highest of all Spanish regions, with around 18 percent of the population testing positive for Covid-19 antibodies, against the national rate of 9.9 percent.

In contrast, regions such as the Canary Islands and Valencia in the east had a prevalence rate below 5.0 percent.

Comments

Comments are closed for this article.